Similar articles

• Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

  Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L. Jensen LO, et al. Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578. Circ Cardiovasc Interv. 2008. PMID: 20031676
• Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature.

  Ehdaie A, Lee MS. Ehdaie A, et al. Minerva Cardioangiol. 2009 Oct;57(5):645-55. Minerva Cardioangiol. 2009. PMID: 19838154 Review.
• Drug-eluting stents and stent thrombosis: a cause for concern?

  Wernick MH, Jeremias A, Carrozza JP. Wernick MH, et al. Coron Artery Dis. 2006 Dec;17(8):661-5. doi: 10.1097/MCA.0b013e32801122b1. Coron Artery Dis. 2006. PMID: 17119373 Review.
• Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?

  Ryan J, Cohen DJ, Pinto DS. Ryan J, et al. Coron Artery Dis. 2006 Dec;17(8):667-71. doi: 10.1097/MCA.0b013e3280111042. Coron Artery Dis. 2006. PMID: 17119374 Review.
• Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.

  Newell MC, Henry CR, Sigakis CJ, Unger BT, Larson DM, Chavez IJ, Burke MN, Traverse JH, Henry TD. Newell MC, et al. Am J Cardiol. 2006 May 1;97(9):1299-302. doi: 10.1016/j.amjcard.2005.11.054. Epub 2006 Mar 10. Am J Cardiol. 2006. PMID: 16635599 Clinical Trial.